At a glance
CDC works with partners in Ethiopia to strengthen the country's public health and clinical systems. CDC delivers quality HIV testing and treatment services and responds to emerging public health threats.
Background
CDC established an office in Ethiopia in 2001. CDC works closely with the Government of Ethiopia (GOE) through the Ministry of Health (MOH) and other partners. Our collaboration strengthens HIV and tuberculosis (TB) prevention and control efforts through support from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).
Download CDC Ethiopia's Fact Sheet
HIV and TB data
HIV/AIDS
Estimated HIV Prevalence (Ages 15-49)
Estimated AIDS Deaths (Age≥15)
Estimated Orphans Due to AIDS
Reported Number Receiving Antiretroviral Therapy (Age≥15)
Tuberculosis (TB)
Estimated TB Incidence
TB Patients with Known HIV-Status who are HIV-Positive
TB Treatment Success Rate
Key activities and accomplishments
Reaching and sustaining HIV epidemic control
In coordination with other U.S. agencies supported by PEPFAR, CDC partners with the GOE to achieve and sustain HIV epidemic control. Through strategic partnerships, CDC focuses on:
- Improving HIV and TB case finding.
- Care and treatment services.
- Performance monitoring.
- Data for decision-making.
- Disease surveillance, laboratory, and health workforce systems.
Building local partner capacity
CDC collaborates with the GOE at federal, regional, local, and site levels by providing technical, financial, and program management assistance. In fiscal year (FY) 2022, 70 percent of CDC funding went to local partnerships. Those partnerships include MOH, Ethiopian Public Health Institute, and Regional Health Bureaus.
HIV treatment services
CDC partners with the GOE to support antiretroviral treatment (ART) services for more than 459,887 people living with HIV (PLHIV) (PEPFAR 2022). To attain epidemic control, the national strategy focuses on improving case finding and durable linkage of newly identified clients to care.
There is also a focus on treatment services and patient-centered treatment, including differentiated service delivery for treatment continuity. The strategy focuses on optimizing ART options and enhancing HIV viral load monitoring and clinical management.
Cervical cancer prevention services are addressed as well.
Prevention of mother-to-child transmission (PMTCT)
In FY22, CDC-supported PMTCT sites where 11,340 HIV-positive pregnant/breastfeeding women received ART to prevent HIV transmission to their children. Approximately 10,038 infants subsequently received an HIV test in the first 12 months after birth. These efforts provided an estimated early infant diagnosis coverage of 94 percent (PEPFAR 2022).
TB and HIV prevention and control
CDC supports a package of evidence-based interventions and services to help reduce TB incidence and mortality among PLHIV. In FY22, 53,372 TB patients were enrolled, and 50,972 were tested for HIV at CDC-supported sites. CDC provided TB preventive treatment for 38,570 PLHIV, scaled up the use of shorter regimens, and achieved an 84% completion rate. CDC continues to scale-up and assist in the diagnosis and prompt treatment of persons with TB.
Services geared towards people at higher risk
CDC technical assistance strengthens confidential, high-quality HIV prevention and treatment services designed for people who are at higher risk. Between 2019-2022, CDC implementing partners supported over 100 clinics serving people at higher risk. This includes providing comprehensive HIV clinical services to over 30,000 female sex workers (PEPFAR 2022).
Voluntary medical male circumcision (VMMC)
VMMC is an HIV prevention strategy that reduces HIV acquisition. Between 2009-2022, CDC supported the national program to provide safe and effective VMMC. The efforts reached over 250,000 males ages 15+ through serial VMMC campaigns and routine services (PEPFAR 2022).
Strengthening laboratory systems
CDC supports the national scale-up of routine HIV viral load monitoring. It is a critical tool in improving treatment quality and individual health outcomes for PLHIV. 82% of eligible clients received viral load testing (PEPFAR 2022).
CDC supports strengthening laboratory personnel capacity, quality assurance systems, and specimen referral networks and improving recovery efforts in conflict-affected regions. CDC assures availability and quality of HIV testing, recent HIV infection testing algorithm, early infant diagnosis, human papillomavirus, and TB diagnosis.
HIV case-based surveillance and response
CDC Ethiopia supports the implementation of the national HIV case-based surveillance, violence against children survey (VACS). VACS is an annual HIV estimation and projection exercise.
Resources
Support for CDC's global HIV and TB efforts
Our success is built on the backbone of science and partnerships.